跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zeftacare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zeftacare
Approved
STANDARD
Zeftacare
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d2a906ea1bfd6d33
Company
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
Type
Standard
Approval Details
Approval Id
d2a906ea1bfd6d33
Drug Approval Philippines Name
Zeftacare
Product Name
Zeftacare
Registration Number
DRP-6180
Brand Name
Zeftacare
Generic Name
Ceftazidime (as Pentahydrate)
Dosage Form
Powder For Injection (I.M./I.V.)
Dosage Strength
1 g
Manufacturer
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
Importer
Aglobal Care Inc.
Distributor
Aglobal Care Inc.
Issuance Date
29 December 2023
Expiry Date
13 March 2029
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d2a906ea1bfd6d33
Type
Standard
Back to Philippines FDA Approvals